Assyro AI

Orange Book product · Brand (NDA)

OTREXUP

METHOTREXATE

Brand (NDA)NDA 204824DISCN ASSERTIO SPECLTY

At a glance

Nov 07, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

15

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 07, 2014

    11 yr 9 mo ago

  2. Patent 11446441 expires

    Listed drug product patent expiration.

    Jan 24, 2026

    5 mo ago

  3. Patent 8562564 expires

    Listed drug product patent expiration.

    Jan 24, 2026

    5 mo ago

  4. Patent 9533102 expires

    Listed drug product patent expiration.

    Jan 24, 2026

    5 mo ago

  5. Patent 9629959 expires

    Listed drug product patent expiration.

    Jan 24, 2026

    5 mo ago

  6. Today

  7. Patent 8021335 expires

    Listed drug product patent expiration.

    Oct 04, 2026

    in 4 mo

  8. Patent 10709844 expires

    Listed drug product patent expiration.

    Mar 10, 2029

    in 2 yr 9 mo

  9. Patent 11684723 expires

    Listed drug product patent expiration.

    Mar 10, 2029

    in 2 yr 9 mo

  10. Patent 9867949 expires

    Listed drug product patent expiration.

    Mar 10, 2029

    in 2 yr 9 mo

  11. Patent 11497753 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  12. Patent 12357642 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  13. Patent 8480631 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  14. Patent 8579865 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  15. Patent 8945063 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  16. Patent 9421333 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

  17. Patent 8814834 expires

    Listed drug product patent expiration.

    May 27, 2031

    in 5 yr

Pharmaceutical detail

Active ingredient

METHOTREXATE

Strength

7.5MG/0.4ML (7.5MG/0.4ML)

Dosage form

SOLUTION

Route

SUBCUTANEOUS

TE code

Not listed

Application

NDA 204824

Product number

005

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (15)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11446441Jan 24, 20265 mo ago
Product
8562564Jan 24, 20265 mo ago
Product
9533102Jan 24, 20265 mo ago
Product
9629959Jan 24, 20265 mo ago
Product
8021335Oct 04, 2026in 4 mo
Product
10709844Mar 10, 2029in 2 yr 9 mo
Product
11684723Mar 10, 2029in 2 yr 9 mo
Product
9867949Mar 10, 2029in 2 yr 9 mo
Product
11497753Mar 19, 2030in 3 yr 10 mo
Product
12357642Mar 19, 2030in 3 yr 10 mo
Product
8480631Mar 19, 2030in 3 yr 10 mo
ProductU-1442
8579865Mar 19, 2030in 3 yr 10 mo
ProductU-1442
8945063Mar 19, 2030in 3 yr 10 mo
ProductU-1442
9421333Mar 19, 2030in 3 yr 10 mo
ProductU-1442
8814834May 27, 2031in 5 yr
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.